Position in NBIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,016,371
+$1,932,040 QoQ
Shares Held
35,697
+15.1% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#195
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$3,240,000
PutShares
28,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $180,168,960 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
588,398 | $42,282,277 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
971,583 | $32,917,229 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
776,464 | $26,920,005 | |
| 4 | VTRS |
Viatris Inc
|
1,275,750 | $20,258,907 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
224,707 | $18,601,244 | |
| 6 | HLN |
Haleon plc
|
908,864 | $8,479,699 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,342 | $7,229,093 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
35,697 | $6,016,371 |
All Filings in NBIX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,016,371 | 35,697 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,084,331 | 31,003 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,352,149 | 23,635 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,329,109 | 23,715 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,836,434 | 30,523 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $3,617,171 | 32,705 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,790,330 | 35,094 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,365,212 | 55,244 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,417,449 | 39,351 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,137,381 | 37,249 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,016,556 | 45,663 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $3,240,000 | 28,800 | Put | Defined | 2023-11-01 | |
| 2023-09-30 | $17,369,099 | 154,392 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $26,607,781 | 282,161 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $6,795,706 | 67,138 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $7,058,902 | 59,100 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $6,270,317 | 59,037 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,061,945 | 10,894 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $7,757,155 | 82,743 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $9,438,621 | 110,821 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $71,667,784 | 747,240 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $35,177,188 | 361,459 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $34,371,551 | 353,435 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $25,806,459 | 269,238 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $12,297,609 | 127,887 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $17,337,176 | 142,108 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,956,806 | 34,163 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||